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for chest pain significantly later than Euro-American women. Once hospital-
ized, diagnostic evaluation between the two groups is similar.
comparable to standard balloon angioplasty. Its effect on reducing late lumen
loss (angiographic restenosis) compared with balloon angioplasty is under-
going evaluation in a randomized, Phase II clinical trial.
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1760-31 Vibrational Coronary Angioplastyj Challenging
Chronic Total Occlusions. Preliminary Clinical Data
Michael R. Rees, Lampros K. Michalis. Department ofPostgraduate Medicine,
University ofKeele, UK
Vibrational angioplasty is a novel method of angioplastywhich is particularly
suitable for the treatment of chronic total occlusions. Vibrational angioplasty
utilises a hand held motor which is attached to a conventional catheter and
guide wire. This device consists of a motor and gearing system producing a
fine rapid reciprocation and random motion in a flexible guide wire. In vitro
studies have shown that this system generates reciprocal motion in a guide
wire with random oscillations of 2 times the reciprocating frequency. The
range of movement of the wire is dependant on the frequency of vibration
and degree of flexibility of the wire together with the lateral motion of the
vibrating 'shuttle' ih the device. We present the first 18 cases (12 male 6 fe-
male, mean age 59.8 yrs range 40-73) of chronic total occlusion treated with
the new version of this device. All patients had symptoms of stable angina.
Arteries treated were left anterior descending:8,left circumflex:4, right coro-
nary artery:6. In all 18 cases there was a failure to cross the lesion with con-
ventional techniques and wires. The mean duration of the occlusions was
17.03 months (range:4-60 months). In 16/18 cases successful crossing was
achieved with vibration In 2118 cases where a wire managed to cross the le-
sion no balloon could subsequently cross the lesion. In 14/18 cases lesions
were crossed successfully by a balloon and PTCA was performed with pres-
sure ranging between 2.5-6 Atm. The post procedural result was: uncom-
plicated in 9/18, complicated by moderate dissection treated conservatively
in 1/18 cases, by major dissection needed stenting in 2/18, compromised
by the evidence of severe diffuse disease distally in 2/18 and regarded as
unsuccessful in 4/18. The total procedural and screening times (mean ± SD)
were 73.2 ± 31 .3 and 41 .2 ± 16.4 min respectively. In conclusion "vibrational
angioplasty" appears to achieve high primary success rates in the recanal-
isation of totally occluded arteries. Further studies are needed to clarify its
mechanism of action, the vessel wall changes due to vibrational' energy and
their impact on restenosis.
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We report the results of initial in-vitro and in-vivo testing of a new, ultrasound-
guided directional coronary atherectomy (GDCA) catheter (DVI, Redwood
City, CA) which is being developed as a potential first-generation clinical prod-
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Therapeutic ultrasonic (195 kHz) catheters with 1.2 or 1.7 mm ball tips for
coronary angioplasty have recently been developed. During the first phase
of a multi-center European trial (CRUSADE) this system was evaluated in 100
patients (86% male, mean age 57 years) with symptomatic coronary artery
disease or acute myocardial infarction. Lesions were located in the LAD (n =
61), CX (n = 17), and RCA (n = 22); 62% were type B or C; 11 lesions were
restenotic, 19 occlusive, 9 longer than 20 mm, 37 calcified, 18 thrombotic,
and 15 collateralised.
Results: The ultrasound catheter crossed 82/100 lesions, adjunctive bal-
loon angioplastywas needed in 98 lesions. There was no death and myocar-
dial infarction, or CABG in the first 24 hours. There was no perforation, but
2 acute vessel closures; intimal cleft or dissection was seen in 17 lesions of
which 1 required stenting. Procedural success was obtained in 93%. At 24
hours 11/100 vessels were reoccluded. At 6 months angiographic follow-up
in 51 patients restenosis (>50% stenosis) occured in 33%.
Conclusions: Therapeutic ultrasound angioplasty is a feasible and safe
new treatment modality. Adjunctive balloon angioplasty is regularly nec-
essary. Preliminary experience suggests usefulness in lesions with visible
thrombus, and undilatable or uncrossable lesions.
1760-41 Initial Multicenter Experience with Therapeutic
Ultrasonic Coronary Angioplasty in Patients
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To assess the angiographic outcome after "cutting" balloon (C-Ball) an-
gioplasty, a technique which uses 3-4 longitudinal microtomes to incise
atheroma reducing vascular barotrauma, we reviewed the cineangiograms of
86 patients (89 lesions) undergoing this procedure in Phase I and II clinical
studies. On-line quantitative angiography (OCA) was used by investigators
to approximate a 1:1 balloon artery ratios (BAR). In the Phase II Pilot study,
adjunct balloon PTCA was not performed unless a >40% residual diameter
stenosis remained after C-Ball. Off-line qualitative morphologic and quanti-
tative angiographic (ImageComm) analyses were performed by independent
Core Laboratory review.
Directional coronary atherectomy has been shown to be a successful
method of percutaneous coronary revascularisation, particularly in large ves-
sels with eccentric stenoses. The application of laser technology to coronary
revascularisation has not been as successful, mainly because of a relatively
high rate of vessel wall perforation. We describe a combination endovascu-
lar imagingllaser atherectomy catheter (Precision Guided Directional Laser
Atherectomy Catheter, PGDLAC) that may overcome these shortcomings by
allowing precision guided intervention.
The catheter consists of a laser cutting device with an integrated imaging
system (fiberoptic or ultrasound). Fiberoptic imaging allows exact position-
ing and orientation of the laser tipped catheter within the vessel lumen, and
visual control of plaque excision. In the second step, the vessel wall mor-
phology is demonstrated using ultrasound, and the result of the intervention
assessed without removing the catheter. Excised plaque fragments are ex-
tracted by way of the catheter, Preliminary results of in vitro experimental ap-
plication of this device in human coronary arteries is promising and confirms
the technical feasibility. Such a device potentially offers the advantages of
effective, precision guided atherectomy in plaques of variable constitution,
with a potential reduction in procedure time and radiation dose.
By combining state of the art imaging and interventional technology, we
have developed a precision guided directional laser atherectomy system that
may provide more effective percutaneous coronary revascularisation than
previously developed techniques.
Tuesday, March 21,1995,4:00 p.m.-5:30 p.m.
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New Devices for Coronary Intervention
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The Precision Guided Directional Laser Atherectomy
Catheter: A New Approach to Percutaneous
Coronary Revascularisation
Raimund Erbel, Thomas Roth, Lothar Koch, Junbo Ge, Michael Haude. Department
of Cardiology, University Essen, Germany
1760-21 Angiographic Outcome After "Cutting" Balloon
Angioplasty
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Two patients in Phase II required intracoronary stents for dissections af-
ter C-Ball and adjunct PTCA. There were no deaths and no patient required
emergency CABG. We conclude that "cutting" balloon PTCA: (1) can be per-
formed safely without an untoward increase in dissections or other angio-
graphic complications; and (2) results in a residual diameter stenosis (29%)
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uct. A 30 MHz, focused transducer is incorporated in the body of the rotat-
ing cutter. Because of the relatively large aperture of the transducer (0.040").
resolution and penetration are superior to stand-alone IVUS catheters. In or-
der to provide maximum rotational stability for imaging, a fixed-wire catheter
configuration has been selected for initial production. The GTO" shaft de-
sign has been adopted for torque control.
11 GDCA catheters, 8 with standard (3.25 mm) balloons and 3 with graft
(4.5 mm) balloons, were tested in 4 normal farm pigs and 3 pigs with in-
jury models of coronary stenosis. All catheters were able to be selectively
directed into the target vesseillesion with good torque control. High resolu-
tion of the images allowed the clear demonstration of intima, venous struc-
tures, pericardium and myocardium. With balloon inflations the adequacy of
engagement of the arterial wall by the cutter was directly visualized.
In vitro testing using fresh porcine aorta compared the cutting ability of
the combined device to the standard GTO. The weights of single cuts were
not significantly different at 10 psi (5.8 mg vs 6.2 mg). and 30 psi (7.9 mg vs
8.1 mg). To fill the nose cone of the GDCA 6.4 cuts were required compared
to 5.8 for the GTO (p = ns). The weights of tissue from the filled nose cones
were not significantly different (26.5 gm vs 20.5 gm).
Summary: High resolution ultrasound imaging has been combined with a
directional atherectomy catheter in a configuration suitable for clinical trials.
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1761-21 Prognostic Value of Creatinine Kinase Elevation
Following Elective Coronary Artery Interventions
Jason T. Tauke, Thomas Q. Kong, Sheridan N. Meyers, Gopal Srinivasan, Paulette
R. Niemys~i, Michele A. Parker, Charles J. Davidson. Northwestern University
Medical School, Chicago IL
Long term prognosis was evaluated in 250 consecutive pts (age 62 ± 12
years, 70% male) who developed creatinine kinase (CK) elevation follow-
ing elective coronary artery interventions (balloon PTCA, directional coronary
atherectomy, TEC atherectomy, and excimer laser). CK levels were obtained
in all pts every 6 hours for at least 24 hours after PTCA. Median follow up
was 2.5 yrs. (0.8, 43) and was obtained in 211 (85%) pts.
Results: Cardiac death occurred in 26/211 (12%) pts at 1.2 ± 1.3 years after
intervention (range 0.0-4.0 years). Univariate predictors of cardiac death in-
clude peak total CK (p < 0.0008), age (p < 0.01), prior coronary artery bypass
surgery (p < 0.04), and Q wave myocardial infarction after PTCA (p < 0.04).
There were no differences in cardiac death rates between devices. Multivari-
ate predictors of cardiac death were peak total CK (p < 0.0004) and age (p <
0.01). Actuarial survival was related to the degree of CK elevation as shown
below:
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\761-3\ Interventlonal Treatment of "Insignificant" Stenoses
Kenneth G. Lehmann, David P. Foley, Rein Melkert, Patrick W. Serruys.
Thoraxcente" Rotterdam, Netherlands; University of Washington, Seattle, WA
Traditionally, coronary lesions with <50% diameter stenosis are consid-
ered clinically insignificant. However, these lesions often initiate acute coro-
nary thrombosis and infarction. Moreover, they are regularly if unintentional
treated when interventionalists "clean up" a diffusely diseased vessel. To
investigate this issue, quantitative analysis was applied to 3,799 discrete
stenosis undergoing PTCA at multiple centers. Of these, 668 (17.9%) pos-
sessed a pre-procedural diameter stenosis of <50%. These lesions were
further subgrouped by terciles (:;:42%, 42-47%, >47%). Compared to diam-
eter stenoses ::::50%, these lesions were significantly more eccentric (p <
0.0001 l, shorter (p < 0.0001 l, located in the LAD (p = 0.0003), and asso-
ciated with multilesion PTCA (p < 0.0001). The therapeutic approach cho-
sen involved larger balloons (balloon/artery ratio = 1.21 vs 1.10, P < 0.0001)
but was accompanied by shorter inflation times (264 sec vs 320 sec, p <
0.0001). Although the acute improvement in MLD was less (0.39 vs 0.81 mm,
Conclusions: CK elevation following elective PTCA is associated with an
increased risk of cardiac death at long term follow up. The degree of CK
elevation and age are independent predictors of late cardiac death.
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Shunichi Miyazaki, Koichi Nakao, Akira Itoh, Satoshi Daikoku, Yusuke Yamamoto,
Hiroshi Nonogi. National Cardiovascular Center, Osaka, Japan
Although low residual stenosis decreases Occurrence of restenosis within
343 months. its influence on long term prognosis remains unknown. There-
fore, 595 consecutive patients with successful elective balloon coronary an-
gioplasty (PTCA) for de novo lesions were divided into 3 groups according
to the percent diameter stenosis (DS) immediately after PTCA. They were
group A = DS < 15% (n = 129), group B = 15% ~ DS ~ 35% (n = 356).
and group C = 35% < DS < 50% (n = 105). Background of each group was
not statistically different in terms of age, history of myocardial infarction (MI),
ejection fraction, distribution of both number of diseased vessels and target
vessels and risk factors such as hypertension, hyperlipidemia and diabetes
mellitus. End points of observation were 1) cardiac death (sudden death, fatal
acute MI and death due to heart failure). 2) non cardiac death, and 3) cardiac
event (acute MI and coronary bypass surgery). Kaplan-Meier survival analysis
showed significant difference among 3 groups. Moreover, event free survival
curve seems to be dependent on the residual stenosis (Figure). Multivariate
analysis using Cox proportional hazard regression model identified that age,
ejection fraction and residual stenosis were the independent determinants
for the long term prognosis.
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Clinical Studies of Coronary Artery Angioplasty
Conclusion: Lower residual stenosis immediately after PTCA is beneficial
not only for preventing early oCcurrence of restenosis but also for long term
prognosis.
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1761-11 Correlation of Residual Stenosis Immediately After
Coronary Angloplasty with Long Term Prognosis
